Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4774370> ?p ?o }
Showing triples 1 to 14 of
14
with 100 triples per page.
- Q4774370 subject Q8279855.
- Q4774370 subject Q8707957.
- Q4774370 abstract "Anti-glycoprotein-210 antibodies (AGPA, anti-gp210, anti-nup210, anti-np210) are directed at gp210 and are found within primary biliary cirrhosis (PBC) patients in high frequency. AGPA recognize the cytoplasmic-oriented carboxyl terminus (tail) of the protein. While AGPA is found as a prognostic marker in only a minority of PBC patients, those that did had higher mortality and were predicted a poor outcome. In addition, patients that responded to ursodeoxycholic acid (UDCA) therapy and, therefore, had AGPA reductions failed to develop end-stage liver disease relative to untreated cohort with anti-gp210 Ab. PBC patients with potentially destructive AGPA have increased expression of Nup210 in the bile duct, a potential immune tolerance-escaping factor.Anti-mitochondrial, anti-centromere and anti-p62 antibodies are also found in (PBC). While patients with AGPA progress toward end-stage liver failure, patients with anti-centromere antibodies often progress toward portal hypertension, further indicating a specific role of the AGPA in PBC.".
- Q4774370 wikiPageWikiLink Q1072420.
- Q4774370 wikiPageWikiLink Q1356761.
- Q4774370 wikiPageWikiLink Q15996961.
- Q4774370 wikiPageWikiLink Q4774331.
- Q4774370 wikiPageWikiLink Q4774427.
- Q4774370 wikiPageWikiLink Q5630176.
- Q4774370 wikiPageWikiLink Q578128.
- Q4774370 wikiPageWikiLink Q8279855.
- Q4774370 wikiPageWikiLink Q8707957.
- Q4774370 comment "Anti-glycoprotein-210 antibodies (AGPA, anti-gp210, anti-nup210, anti-np210) are directed at gp210 and are found within primary biliary cirrhosis (PBC) patients in high frequency. AGPA recognize the cytoplasmic-oriented carboxyl terminus (tail) of the protein. While AGPA is found as a prognostic marker in only a minority of PBC patients, those that did had higher mortality and were predicted a poor outcome.".
- Q4774370 label "Anti-glycoprotein-210 antibodies".